Department of Pathology, Stanford University, Palo Alto, CA 94304, USA.
J Immunol. 2011 Feb 1;186(3):1477-85. doi: 10.4049/jimmunol.1000454. Epub 2010 Dec 20.
Plasmacytoid dendritic cells (pDC) produce large amounts of type I IFN in response to invading pathogens, but can also suppress immune responses and promote tolerance. In this study, we show that in mice, these functions are attributable to two distinct pDC subsets, one of which gives rise to the other. CD9(pos)Siglec-H(low) pDC secrete IFN-α when stimulated with TLR agonists, induce CTLs, and promote protective antitumor immunity. By contrast, CD9(neg)Siglec-H(high) pDC secrete negligible amounts of IFN-α, induce Foxp3(+) CD4(+) T cells, and fail to promote antitumor immunity. Although newly formed pDC in the bone marrow are CD9(pos) and are capable of producing IFN-α, after these cells traffic to peripheral tissues, they lose CD9 expression and the ability to produce IFN-α. We propose that newly generated pDC mobilized from the bone marrow, rather than tissue-resident pDC, are the major source of IFN-α in infected hosts.
浆细胞样树突状细胞 (pDC) 在受到入侵病原体的刺激时会产生大量的 I 型干扰素,但也可以抑制免疫反应并促进耐受。在这项研究中,我们表明,在小鼠中,这些功能归因于两个不同的 pDC 亚群,其中一个亚群由另一个亚群产生。CD9(pos)Siglec-H(low)pDC 在受到 TLR 激动剂刺激时会分泌 IFN-α,诱导 CTL,并促进保护性抗肿瘤免疫。相比之下,CD9(neg)Siglec-H(high)pDC 分泌的 IFN-α 数量可忽略不计,诱导 Foxp3(+)CD4(+)T 细胞,并且不能促进抗肿瘤免疫。尽管骨髓中新生的 pDC 是 CD9(pos),并且能够产生 IFN-α,但在这些细胞迁移到外周组织后,它们会失去 CD9 的表达和产生 IFN-α 的能力。我们提出,从骨髓动员而来的新生成的 pDC,而不是组织驻留的 pDC,是感染宿主中 IFN-α 的主要来源。